BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27499261)

  • 21. Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1.
    Mitchell DC; Abdelrahim M; Weng J; Stafford LJ; Safe S; Bar-Eli M; Liu M
    J Biol Chem; 2006 Jan; 281(1):51-8. PubMed ID: 16260418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased Expression of BNC1 and BNC2 Is Associated with Genetic or Epigenetic Regulation in Hepatocellular Carcinoma.
    Wu Y; Zhang X; Liu Y; Lu F; Chen X
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung.
    Shibata T; Kokubu A; Miyamoto M; Hosoda F; Gotoh M; Tsuta K; Asamura H; Matsuno Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
    Oncogene; 2010 Aug; 29(33):4671-81. PubMed ID: 20543864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repression of integrin-linked kinase by antidiabetes drugs through cross-talk of PPARγ- and AMPKα-dependent signaling: role of AP-2α and Sp1.
    Hahn SS; Tang Q; Zheng F; Zhao S; Wu J; Chen J
    Cell Signal; 2014 Mar; 26(3):639-47. PubMed ID: 24361375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of genes associated with human hepatocellular carcinogenesis.
    Kondoh N; Wakatsuki T; Ryo A; Hada A; Aihara T; Horiuchi S; Goseki N; Matsubara O; Takenaka K; Shichita M; Tanaka K; Shuda M; Yamamoto M
    Cancer Res; 1999 Oct; 59(19):4990-6. PubMed ID: 10519413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation.
    Qiu X; Zhang L; Lu S; Song Y; Lao Y; Hu J; Fan H
    Oncol Rep; 2014 Jan; 31(1):202-8. PubMed ID: 24247422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus regulation of Raf1 promoter activity through activation of transcription factor AP-2α.
    Qu J; Li J; Chen K; Qin D; Li K; Sheng Y; Zou C; Wang S; Huang A; Tang H
    Arch Virol; 2013 Apr; 158(4):887-94. PubMed ID: 23224762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2.
    Stefanska B; Suderman M; Machnes Z; Bhattacharyya B; Hallett M; Szyf M
    Carcinogenesis; 2013 Dec; 34(12):2738-49. PubMed ID: 23955541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of DAPK1 as a novel transcriptional target of BRMS1.
    Qiao X; Yang X; Zhou Y; Mei X; Dou J; Xie W; Li G; Wang Y; Qiao S; Hu J; Wu Y
    Int J Oncol; 2017 May; 50(5):1760-1766. PubMed ID: 28339067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypermethylation of a small CpGuanine-rich region correlates with loss of activator protein-2alpha expression during progression of breast cancer.
    Douglas DB; Akiyama Y; Carraway H; Belinsky SA; Esteller M; Gabrielson E; Weitzman S; Williams T; Herman JG; Baylin SB
    Cancer Res; 2004 Mar; 64(5):1611-20. PubMed ID: 14996719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
    Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M
    Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of nucleolar and coiled-body phosphoprotein 1 is associated with the mechanism of tumorigenesis in hepatocellular carcinoma.
    Duan X; Zhang J; Liu S; Zhang M; Wang Q; Cheng J
    Oncol Rep; 2013 Nov; 30(5):2220-8. PubMed ID: 23970161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas.
    Iliopoulos D; Satra M; Drakaki A; Poultsides GA; Tsezou A
    Int J Oncol; 2009 Feb; 34(2):391-9. PubMed ID: 19148473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter Hypomethylation Is Responsible for Upregulated Expression of HAI-1 in Hepatocellular Carcinoma.
    Du X; Wu L; Ur Rahman MS; Teng X; Teng L; Ye J; Cao J
    Dis Markers; 2019; 2019():9175215. PubMed ID: 31558918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression analysis of 6p22 genomic gain in retinoblastoma.
    Orlic M; Spencer CE; Wang L; Gallie BL
    Genes Chromosomes Cancer; 2006 Jan; 45(1):72-82. PubMed ID: 16180235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of the Histone Chaperones HSPA8 and DEK on Tumor Immunity in Hepatocellular Carcinoma.
    Yang C; Shao Y; Wang X; Wang J; Wang P; Huang C; Wang W; Wang J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of transcription factor AP-2 stimulates the PA promoter of the human uracil-DNA glycosylase (UNG) gene through a mechanism involving derepression.
    Aas PA; Peña-Diaz J; Liabakk NB; Krokan HE; Skorpen F
    DNA Repair (Amst); 2009 Jul; 8(7):822-33. PubMed ID: 19411194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
    Cheng YH; Handwerger S
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein.
    Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C
    Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.